Navigation Links
PharmSource Lead Sheet Adds Coverage of Medical Devices and Diagnostics
Date:12/12/2012

Fairfax, VA (PRWEB) December 11, 2012

PharmSource Information Services, Inc. (PharmSource) has announced that it now offers a concise data-driven resource that delivers targeted business opportunities to companies supporting the medical device/diagnostic arena, worldwide.

This offering, known as the PharmSource Lead Sheet: Devices & Diagnostics Edition, provides pipeline updates regarding medical device and diagnostic candidates in the clinical trial process, as well as approvals and clearances in the US and abroad. Weekly updates signal when medical devices or diagnostics move into a new development stage. Product coverage includes pre-feasibility through post-marketing, acquisitions and alliances. In addition, users are informed company acquisitions and alliances, corporate-level financings and other deals and events that signal corporate expansions or contractions.

The availability of a weekly supply of fresh intelligence on the medical device and diagnostic world in this single-source, user-friendly resource is expected to be a major boon for CROs, CMOs and other companies providing services in this industry.

This resource enables service providers to easily identify new opportunities based on criteria that are relevant to specific needs (i.e., therapeutic specialty; device/diagnostic purpose or type; approval status; class; lifespan; invasiveness; material; and more). Hotlinks go immediately to deeper information about both the product and the company. In addition, verified contacts are provided for each company reported in the weekly report to help business development teams start calls at the right level.

For a limited time, PharmSource is offering a complimentary walk-through of the PharmSource Lead Sheet: Devices & Diagnostics Edition for qualified companies. For more information, contact PharmSource directly at 1-703-383-4903, ext. 112 / info(at)pharmsource(dot)com.

About PharmSource®
PharmSource specializes in bringing together buyers and sellers of contract services related to drug development and manufacturing. Founded in 1996, this globally respected provider of proprietary databases and insightful market intelligence serves clients’ strategic information needs and helps them to be aware of and fully understand critical sourcing factors and make optimal operating and strategic decisions. To learn more, visit PharmSource at http://www.pharmsource.com, or contact info(at)pharmsource(dot)com / phone: 1-703-383-4903 (USA, eastern time-zone).

Read the full story at http://www.prweb.com/releases/PharmSource/Dec2012/prweb10194466.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Northwest Bio Implements Major Balance Sheet Clean-Up
2. UMass Amherst polymer scientists, physicists develop new way to shape thin gel sheets
3. Simple, cheap way to mass-produce graphene nanosheets
4. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
5. Research Alert -- Empire Asset Management Co. Initiates Coverage on Exact Sciences (NASDAQ: EXAS)
6. A New Dawn in Cosmetics Coverage: Cosmetics Design Launches Asia-Pacific News Website
7. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
8. DiaTech Life Sciences Announces Medical Advisory Board
9. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
10. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
11. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
Breaking Biology Technology:
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):